Cornerstone Advisors’s DexCom DXCM Stock Holding History

Cornerstone Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,600	Closed	-$1.25M	–	195
2025 Q3	$1.25M	Sell	18,600 -7,300	-28%	-$578K	0.04%	193
2025 Q2	$2.26M	Sell	25,900 -600	-2%	-$47K	0.08%	172
2025 Q1	$1.81M	Hold	26,500	–	–	0.08%	184
2024 Q4	$2.06M	Hold	26,500	–	–	0.08%	173
2024 Q3	$1.78M	Buy	26,500 +5,300	+25%	+$435K	0.07%	196
2024 Q2	$2.4M	Sell	21,200 -1,300	-6%	-$164K	0.1%	172
2024 Q1	$3.12M	Buy	22,500 +2,200	+11%	+$277K	0.13%	172
2023 Q4	$2.52M	Sell	20,300 -15,100	-43%	-$1.54M	0.11%	184
2023 Q3	$3.3M	Sell	35,400 -5,600	-14%	-$631K	0.15%	154
2023 Q2	$5.27M	Sell	41,000 -5,000	-11%	-$605K	0.25%	104
2023 Q1	$5.34M	Buy	+46,000	New	+$5.15M	0.25%	94
2022 Q2	–	Sell	-4,000	Closed	-$512K	–	191
2022 Q1	$512K	Hold	4,000	–	–	0.03%	158
2021 Q4	$537K	Hold	4,000	–	–	0.03%	171
2021 Q3	$547K	Hold	4,000	–	–	0.03%	167
2021 Q2	$427K	Sell	4,000 -20,000	-83%	-$1.92M	0.03%	186
2021 Q1	$2.16M	Hold	24,000	–	–	0.19%	124
2020 Q4	$2.22M	Buy	24,000 +16,000	+200%	+$1.43M	0.19%	112
2020 Q3	$824K	Buy	+8,000	New	+$836K	0.07%	153

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cornerstone Advisors's DXCM Position: Q4 2025 in Review

Cornerstone Advisors sold out of DexCom (DXCM) in Q4 2025, closing a stake of 18,600 shares — an estimated $1.25M sold.

Cornerstone Advisors first reported a position in DXCM in Q3 2020 and held it in 18 quarters. The position peaked at $5.34M in Q1 2023. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Cornerstone Advisors reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Cornerstone Advisors sold 18,600 DexCom shares in Q4 2025, an estimated $1.25M.
Cornerstone Advisors first reported a position in DexCom in Q3 2020 and held it in 18 quarters.
Cornerstone Advisors's DexCom position peaked at $5.34M in Q1 2023.
921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Cornerstone Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.